S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
S&P 500   3,948.72 (+0.30%)
DOW   32,105.25 (+0.23%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
NASDAQ:ALR

AlerisLife - ALR Stock Forecast, Price & News

1.32
+0.01 (+0.76%)
(As of 03/20/2023 08:00 PM ET)
Add
Compare
Today's Range
1.30
▼
1.32
50-Day Range
0.65
▼
1.34
52-Week Range
0.55
▼
2.70
Volume
111,900 shs
Average Volume
251,310 shs
Market Capitalization
$43.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AlerisLife MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.46mentions of AlerisLife in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From -1.04 to -0.54 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.76 out of 5 stars

Medical Sector

768th out of 986 stocks

Skilled Nursing Care Facilities Industry

2nd out of 3 stocks

See Top Rated MarketRank™ Stocks Here

ALR stock logo

About AlerisLife (NASDAQ:ALR) Stock

AlerisLife, Inc. engages in the operation of senior living communities and rehabilitation and wellness services clinics. It operates through the Senior Living and Rehabilitation and Wellness Services segments. The Senior Living segment is involved in the operation of independent assisted living communities, skilled nursing facilities, and continuing care retirement communities. It also offers memory care living units specializing in the care of those with Alzheimer's. The Rehabilitation and Wellness Services segment provides physical, occupational, speech, and other specialized therapy services in inpatient and outpatient clinics. The company was founded by Barry Michael Portnoy and Gerard Michael Martin in April 2000 and is headquartered in Newton, MA.

Receive ALR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AlerisLife and its competitors with MarketBeat's FREE daily newsletter.

ALR Stock News Headlines

March 21, 2023 | investing.com
Alerislife (ALR) Earnings Dates & Reports
March 20, 2023 | finance.yahoo.com
AlerisLife Announces Closing of Tender Offer
March 23, 2023 | Weiss Ratings (Ad)
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
February 8, 2023 | wsj.com
ALR ALERT: Levi & Korsinsky, LLP Announces an Investigation into the Fairness of the Acquisition of AlerisLife Inc. ("ALR") by ABP Acquisition LLC
February 6, 2023 | benzinga.com
SHAREHOLDER ALERT: Weiss Law Investigates AlerisLife Inc.
February 6, 2023 | benzinga.com
Moore Kuehn Encourages ALR, CEMI, LPTX, and ATCX Investors to Contact Law Firm
February 3, 2023 | benzinga.com
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of AlerisLife Inc. - ALR
February 3, 2023 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating AlerisLife Inc. Buyout
March 23, 2023 | Weiss Ratings (Ad)
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
February 3, 2023 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether AlerisLife Inc. has obtained a Fair Price in its transaction with ABP
February 3, 2023 | investorplace.com
Why Is AlerisLife (ALR) Stock Up 58% Today?
February 3, 2023 | technews.tmcnet.com
ALR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of AlerisLife Inc. Is Fair to Shareholders
January 26, 2023 | reuters.com
ALR.O - | Stock Price & Latest News | Reuters
January 23, 2023 | reuters.com
ALR.A - | Stock Price & Latest News | Reuters
See More Headlines
Receive ALR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AlerisLife and its competitors with MarketBeat's FREE daily newsletter.

ALR Company Calendar

Today
3/23/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Skilled nursing care facilities
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ALR
CUSIP
N/A
CIK
1159281
Web
www.alerislife.com
Phone
(617) 796-8387
Fax
617-796-8385
Employees
10,400
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
-1.20
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-29,920,000.00
Net Margins
-5.34%
Pretax Margin
-5.29%
Return on Equity
-20.78%
Return on Assets
-9.02%

Debt

Debt-to-Equity Ratio
0.45
Current Ratio
1.58
Quick Ratio
1.58

Sales & Book Value

Annual Sales
$707.97 million
Price / Sales
0.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
5.72 per share
Price / Book
0.23

Miscellaneous

Outstanding Shares
32,609,000
Free Float
29,870,000
Market Cap
$43.04 million
Optionable
Optionable
Beta
0.96

Key Executives

  • Adam David Portnoy
    Chairman & Co-Managing Director
  • Jeffrey C. Leer
    President & Chief Executive Officer
  • Philip Benjamson
    Chief Operating Officer & Senior Vice President
  • Heather Pereira
    Chief Financial Officer, Treasurer & Senior VP
  • Priti Jindal
    Chief Medical Officer

Key Competitors

View All Competitors













ALR Stock - Frequently Asked Questions

How have ALR shares performed in 2023?

AlerisLife's stock was trading at 0.55 at the beginning of the year. Since then, ALR stock has increased by 140.0% and is now trading at 1.32.
View the best growth stocks for 2023 here.

Are investors shorting AlerisLife?

AlerisLife saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 66,500 shares, a decline of 42.8% from the February 13th total of 116,300 shares. Based on an average trading volume of 211,900 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.3% of the company's shares are short sold.
View AlerisLife's Short Interest.

What is AlerisLife's stock symbol?

AlerisLife trades on the NASDAQ under the ticker symbol "ALR."

How do I buy shares of AlerisLife?

Shares of ALR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AlerisLife's stock price today?

One share of ALR stock can currently be purchased for approximately 1.32.

How much money does AlerisLife make?

AlerisLife (NASDAQ:ALR) has a market capitalization of $43.04 million and generates $707.97 million in revenue each year. The company earns $-29,920,000.00 in net income (profit) each year or -1.20 on an earnings per share basis.

How many employees does AlerisLife have?

The company employs 10,400 workers across the globe.

How can I contact AlerisLife?

AlerisLife's mailing address is Two Newton Place 255 Washington Street Suite 230, Newton MA, 02458. The official website for the company is www.alerislife.com. The company can be reached via phone at (617) 796-8387, via email at ir@alerislife.com, or via fax at 617-796-8385.

This page (NASDAQ:ALR) was last updated on 3/23/2023 by MarketBeat.com Staff